Alligator to Present New Mitazalimab Data at ASCO GI 2026
LUND, Sweden | January 9, 2026 — Alligator Bioscience announced that new clinical data from its Phase 1b/2 OPTIMIZE-1...
Phase 2 clinical data
Advertisement
Kyverna Therapeutics Reports Breakthrough Phase 2 Results for KYV-101 in Myasthenia Gravis
Emeryville, California, October 29, 2025 — Kyverna Therapeutics Inc. (Nasdaq: KYTX) announced positive interim Phase 2 data from the...
Advertisement
